Capital Change Notices - NZ & AU ESPS

Capital Change Notice


7 April 2025

Issue of ordinary shares
This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel
Healthcare Corporation Limited (“FPH”) in connection with one or more of FPH’s employee share plans.

Section 1: Issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZFAPE0001S2
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 101,280
Nominal value (if any) Not applicable
Issue/acquisition/redemption price per security NZ$33.7241
Nature of the payment (for example, cash or
other consideration)
Cash
Amount paid up (if not in full) In full
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1

0.01728%
For an issue of Convertible Financial Products
or Options, the principal terms of Conversion
(for example the Conversion price and
Conversion date and the ranking of the
Financial Product in relation to other Classes
of Financial Product) or the Option (for
example, the exercise price and exercise date)
Not applicable
Reason for issue/acquisition/redemption and
specific authority for
issue/acquisition/redemption/ (the reason for
change must be identified here)
Issue of shares to the Trustees of the NZ Scheme to be
held on trust under the NZ Scheme for those New
Zealand employees accepting an offer to participate in
the scheme (with a discount of up to $500 per employee),
in accordance with the terms of the scheme as set out in
the Trust Deed dated 26 September 2019.
Total number of Financial Products of the
Class after the
issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total
number of Financial Products of the Class held
as Treasury Stock after the
issue/acquisition/redemption.
Total number of ordinary shares on issue as at the date of
this notice after the issues disclosed in this notice
(excluding Treasury Stock): 586,253,927

Total number of ordinary shares held as Treasury Stock
after the issues disclosed in this notice: Nil
In the case of an acquisition of shares,
whether those shares are to be held as
treasury stock
Not applicable

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
Directors’ resolution, Listing Rule 4.6
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
The ordinary shares issued rank pari passu with the
existing ordinary shares
Date of issue/acquisition/redemption
2
4 April 2025
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Raelene Leonard
Contact person for this announcement Raelene Leonard
Contact phone number +64 9 610 4803
Contact email address Raelene.Leonard@fphcare.co.nz
Date of release through MAP

7 April 2025




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).

---

Capital Change Notice


7 April 2025

Issue of ordinary shares
This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel
Healthcare Corporation Limited (“FPH”) in connection with one or more of FPH’s employee share plans.

Section 1: Issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZFAPE0001S2
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 2,727
Nominal value (if any) Not applicable
Issue/acquisition/redemption price per security NZ$33.7241 (AU$30.6249)
Nature of the payment (for example, cash or
other consideration)
Cash payment
Amount paid up (if not in full) In full
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1

0.00047%
For an issue of Convertible Financial Products
or Options, the principal terms of Conversion
(for example the Conversion price and
Conversion date and the ranking of the
Financial Product in relation to other Classes
of Financial Product) or the Option (for
example, the exercise price and exercise date)
Not applicable
Reason for issue/acquisition/redemption and
specific authority for
issue/acquisition/redemption/ (the reason for
change must be identified here)
Issue of shares to David Michael Boyle and Victor Riitano
to be held on trust under the Australian Scheme for those
Australian employees accepting an offer to participate in
the scheme (with a discount of up to $500 per employee),
in accordance with the terms of the scheme as set out in
the Trust Deed dated 20 December 2001, as amended
on 28 January 2005, 27 July 2009, 2 July 2012, 27
August 2015 and 11 October 2019.
Total number of Financial Products of the
Class after the
issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total
number of Financial Products of the Class held
as Treasury Stock after the
issue/acquisition/redemption.
Total number of ordinary shares on issue as at the date of
this notice after the issues disclosed in this notice
(excluding Treasury Stock): 586,256,654.

Total number of ordinary shares held as Treasury Stock
after the issues disclosed in this notice: Nil
In the case of an acquisition of shares,
whether those shares are to be held as
treasury stock
Not applicable

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
Directors’ resolution, Listing Rule 4.6
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
The ordinary shares issued rank pari passu with the
existing ordinary shares
Date of issue/acquisition/redemption
2
4 April 2025
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Raelene Leonard
Contact person for this announcement Raelene Leonard
Contact phone number +64 9 610 4803
Contact email address Raelene.Leonard@fphcare.co.nz
Date of release through MAP

7 April 2025




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).